October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

When prostate cancer cells burst as a result of menadione treatment, there is no risk of metastasis. This event represents a ...

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

An Oklahoma cancer survivor is doing his part in supporting others by sharing his journey with those going through similar ...

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...

City of Hope researchers are now focusing on whether the reduction in MDSCs is associated with improved clinical outcomes in ...